急性放射病的分度和治疗——介绍美国国家战略储备辐射工作组关于急性放射病治疗的建议之二

闵锐; 潘真; 李雨

闵锐 , 潘真 , 李雨

文章导航 > 国际放射医学核医学杂志 > 2005, 29 > 6: (272-278)

引用本文:

Citation:

急性放射病的分度和治疗——介绍美国国家战略储备辐射工作组关于急性放射病治疗的建议之二

200433 上海, 第二军医大学海军医学系放射医学教研室
中图分类号: R818.05

Degree and therapy of acute radiation syndromes——Introduction of a suggestion on acute radiation sickness therapy made by strategic national stockpile radiation working group of USA. Part 2

Department of Radiation Medicine, Second Military Medical University, Shanghai 200433, China
CLC number: R818.05

摘要: 根据受照剂量和生理反应所制定的造血综合征治疗方案包括造血因子治疗、输血以及选择病例的干细胞移植。其他医学治疗措施根据临床征兆和症状的发展而定,包括使用抗生素(奎诺酮,抗滤过性病原体治疗和抗真菌制剂),止吐剂和止痛剂。由于辐射造成的强烈的心理冲击,无论照射剂量多大,对于那些受照者以及家属和朋友都要给予社会心理支持。孕妇的医学处理必须考虑对胎儿的危害。在涉及放射性碘的恐怖袭击和偶然事故中,预防照射引起的甲状腺恶性病变的措施也包括在建议之中,儿童和青少年更是重点预防对象。
- 急性放射病 /
- 治疗 /
- 心理支持 /
- 甲状腺
Abstract: Recommendations based on radiation dose and physiologic response are made for treatment of the hematopoietic syndrome. Therapy includes treatment with hematopoietic cytokines, blood transfusion, and stem-cell transplantation in selected cases. Additional medical management based on the evolution of clinical signs and symptoms includes the use of antimicrobial agents (quinolones, antiviral therapy, and antifungal agents), antiemetic agents, and analgesic agents. Because of the strong psychological impact of a possible radiation exposure, psychosocial support will be required for those exposed, regardless of the dose, as well as for family and friends. Treatment of pregnant women must account for risk to the fetus. For terrorist or accidental events involving exposure to radioiodines, prophylaxis against malignant disease of the thyroid is also recommended, particularly for children and adolescents.
- acute radiation syndrome /
- therapy /
- psychosocial support /
- thyroid
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Bedell C. Pegfilgrastim for chemotherapy-induced neutropenia[J].Clin J Oncol Nurs, 2003, 7(1):55-56.
[2]	Holmes FA, O'Shaughnessy JA, Vukelja S, et al. Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage Ⅱ or stage Ⅲ/Ⅳ breast cancer[J]. J Clin Oncol, 2002, 20(3):727-731.
[3]	Hebert PC, Fergusson D, Blajchman MA, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions[J]. JAMA, 2003, 289(15):1941-1949.
[4]	Blajchman MA. Immunomodulation and blood transfusion[J]. Am J Ther, 2002, 9(5):389-395.
[5]	Maekawa K. Overview of medical care for highly exposed victims in the Tokaimura accident[A]. Ricks RC, Berger ME, O'Hara FM, eds.The Medical Basis for Radiation Accident Preparedness:The Clinical Care of Victims[C]. New York:Parthenon, 2002.313-318.
[6]	Fliedner TM, Graessle D, Reimers K, et al. Stem cell transplantation in radiation accidents[A]. Medical Aspects of Radiation Emergency:The Criticality Accident in Tokaimura. Chiba[C]. Japan:National Institute of Radiological Sciences, 2000. 228-235.
[7]	Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer[J].Clin Infect Dis, 2002, 34(6):730-751.
[8]	Hughes WT. Use of antimicrobial agents for treatment of infection in the neutropenic immunocompromised patient[A]. Ricks RC, Berger ME, O'Hara FM, et al. The Medical Basis for Radiation-Accident Preparedness. The Clinical Care of Victims[C]. Washington DC:Parthenon, 2002. 117-129.
[9]	Brook I, Elliott TB, Ledney GD, et al. Management of postirradiation sepsis[J]. Mil Med, 2002, 167(2 suppl):105-106.
[10]	National council on Radiation Protection and Measurements.Management of Terrorist Events Involving Radioactive Material.NCRP Report No. 138[C]. Bethesda, MD, 2001. 125-134.
[11]	U.S. Department of Health and Human Services, U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Guidance:Potassium iodide as a thyroid blocking agent in radiation emergencies. December 2001. www.fda.gov/cder/guidance/4825fnl.pdf.

[1]	王欣茹 , 罗庆良 , 王宝勤 , 董书魁 . 中子急性放射病的特点及治疗研究进展. 国际放射医学核医学杂志, 2003, 27(4): 178-181.
[2]	叶根耀 . 核辐射事故的医学处理新进展. 国际放射医学核医学杂志, 2003, 27(3): 123-127.
[3]	邓婕 , 段东 . 甲状腺微小乳头状癌的治疗进展. 国际放射医学核医学杂志, 2018, 42(5): 463-467. doi: 10.3760/cma.j.issn.1673-4114.2018.05.014
[4]	刘丽波 , 张海英 . 放射性膀胱炎的治疗和预防. 国际放射医学核医学杂志, 2000, 24(3): 135-137.
[5]	陆蒋惠文 , 张舒羽 , 张杰 , 余道江 . 放射性皮肤损伤的治疗进展. 国际放射医学核医学杂志, 2021, 45(7): 461-469. doi: 10.3760/cma.j.cn121381-202005043-00030
[6]	陶吉 , 宿兵 , 王久存 , 田梅 . 临床医学影像技术在高原病诊断和治疗评估中的应用. 国际放射医学核医学杂志, 2023, 47(2): 112-117. doi: 10.3760/cma.j.cn121381-202205029-00263
[7]	张紫薇 , 程刚 . 放射性核素在嗜铬细胞瘤诊断与治疗中的应用进展. 国际放射医学核医学杂志, 2019, 43(1): 82-87. doi: 10.3760/cma.j.issn.1673-4114.2019.01.014
[8]	陈跃 . ¹³¹I治疗非毒性甲状腺肿的研究进展. 国际放射医学核医学杂志, 2000, 24(3): 122-124.
[9]	唐忠群 . ¹³¹I治疗非毒性多发结节性甲状腺肿. 国际放射医学核医学杂志, 2000, 24(3): 120-121.
[10]	范我 . 用于肿瘤治疗的放射性药物. 国际放射医学核医学杂志, 2004, 28(1): 21-25.

点击查看大图

计量

文章访问数: 1343
HTML全文浏览量: 103
PDF下载量: 3

急性放射病的分度和治疗——介绍美国国家战略储备辐射工作组关于急性放射病治疗的建议之二

200433 上海, 第二军医大学海军医学系放射医学教研室

收稿日期: 2005-04-07

关键词:

摘要: 根据受照剂量和生理反应所制定的造血综合征治疗方案包括造血因子治疗、输血以及选择病例的干细胞移植。其他医学治疗措施根据临床征兆和症状的发展而定,包括使用抗生素(奎诺酮,抗滤过性病原体治疗和抗真菌制剂),止吐剂和止痛剂。由于辐射造成的强烈的心理冲击,无论照射剂量多大,对于那些受照者以及家属和朋友都要给予社会心理支持。孕妇的医学处理必须考虑对胎儿的危害。在涉及放射性碘的恐怖袭击和偶然事故中,预防照射引起的甲状腺恶性病变的措施也包括在建议之中,儿童和青少年更是重点预防对象。